Buy & Sell US Bancorp (USB) – US Bancorp Price Today
Aura AI Summary
Key Stats
- $86.38BMarket Cap
- FinancialsSector
- -7.47%3M Drawdown
- -Enterprise Value
- 3.7%Dividend Yield
- 91 daysTypical Hold Time
US Bancorp (USB) is currently valued at a market capitalization of $86.38B. Over the past 52 weeks, US Bancorp has traded between a low of $42.69 and a high of $60.69, highlighting its annual price range. Over the past three months, US Bancorp has recorded a drawdown of -7.47%, reflecting recent price volatility. US Bancorp offers a dividend yield of 3.7%, with the most recent dividend of $0.52 paid on 31 Mar 26. On average, investors hold US Bancorp for approximately 91 days, indicating typical investor behavior on the platform.
About US Bancorp
As a diversified financial-services provider, U.S. Bancorp is one of the nation's largest regional banks, with branches in well over 20 states, primarily in the Western and Midwestern United States. The bank offers many services, including retail banking, commercial banking, trust and wealth services, credit cards, mortgages, and other payments capabilities.
Most Recent News
Digital Realty launches Malaysia data center operations to boost Southeast Asia's digital and AI infrastructure.
Digital Realty has officially launched its Malaysia operations with a new data center campus in Cyberjaya, aiming to expand its capacity to 32 MW. This development integrates Malaysia into Digital Realty's global network, supporting AI and data-drive...

Lockheed Martin and Boeing lag space stock rally; LMT upgraded to strong buy, BA to buy.
Lockheed Martin (LMT) and Boeing (BA) have not joined the recent surge in space-related stocks, largely due to ULA's lack of cost innovation and limited market fit compared to SpaceX. Their space segments contribute only a small portion of overall re...

Novartis to present key Phase III data on Rhapsido for chronic urticaria and food allergy at EAACI 2026.
Novartis will showcase results from multiple clinical trials of Rhapsido (remibrutinib) at the EAACI Congress 2026, including pivotal Phase III data for chronic inducible urticaria and extension data for chronic spontaneous urticaria. The presentatio...
